Original Source(s)
Related Content
Can Endotoxin-Targeted Care Improve Sepsis Outcomes?
Biomarker-guided patient selection may help identify patients with sepsis who could benefit from endotoxin-targeted therapy, although confirmatory evidence is still needed.
July 20, 2026
-
3 min
FDA Expands Gene Therapy for Younger Patients
Exagamglogene autotemcel is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.
July 2, 2026
-
3 min
Congo Ebola Outbreak Strains Care Delivery
“We live with fear in our stomachs"
by Amy Maxmen
June 5, 2026
-
10 min
